Sanofi wins ICC case over recalled heartburn drug
Zantac on sale in Los Angeles before it was taken off the market in 2019 (Credit: Shutterstock/calimedia)
French pharmaceuticals group Sanofi says an ICC tribunal has ruled in its favour in a dispute with Germany’s Boehringer Ingelheim over US litigation liabilities arising from withdrawn heartburn drug Zantac.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.
Subscribe now